Major geographical variations in elective coronary revascularization by stents or surgery in England

European Journal of Cardio-thoracic Surgery

Volumn 47, Issue 5, 2015, Pages 855-859

  Baig, Sheharyar S ^a   Altman, Douglas G ^b   Taggart, David P ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Coronary artery bypass graft; Geographical variation; Percutaneous coronary intervention; Stent; Unwarranted variation

Indexed keywords

ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY STENTING; ELECTIVE SURGERY; EMERGENCY SURGERY; HEALTH CARE PRACTICE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED KINGDOM; CLINICAL TRIAL; CORONARY ARTERY DISEASE; MULTICENTER STUDY; PROCEDURES; TREATMENT OUTCOME; UTILIZATION;

CORONARY ARTERY DISEASE; ELECTIVE SURGICAL PROCEDURES; ENGLAND; HUMANS; MYOCARDIAL REVASCULARIZATION; TREATMENT OUTCOME;

EID: 84929157137     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu276     Document Type: Article

References (13)

1. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-2555.
2. Ludman P. British Cardiovascular Intervention Society Audit Returns. 2010. http://www.bcis.org.uk/pages/page_box_contents.asp?PageID=746.
3. Taggart DP, Thomas B, Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg 2006;82:1966-75.
4. Taggart DP. Lessons learned from the SYNTAX trial for multivessel and left main stem coronary artery disease. Curr Opin Cardiol 2011;26: 502-7.
5. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Stahle E et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year followup of the SYNTAX trial. Eur Heart J 2011;32:2125-34.
6. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005;1:219-27.
7. Hannan EL, Racz MJ, Gold J, Cozzens K, Stamato NJ, Powell T et al. Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice? Circulation 2010;121:267-75.
8. Gibbons RJ. Get with the guidelines: a new chapter? Circulation 2010;121: 194-6.
9. Chandrasekharan DP, Taggart DP. Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. Eur J Cardiothorac Surg2011;39:912-7.
10. Tu JV, Ko DT, Guo H, Richards JA, Walton N, Natarajan MK et al. Determinants of variations in coronary revascularization practices. CMAJ 2012;184:179-86.
11. Weerasinghe DP, Yusuf F, Parr NJ. Geographic variation in invasive cardiac procedure rates in New South Wales, Australia. J Public Health 2010;18: 209-21.
12. Chan PS, Patel MR, Klein LW, Krone RJ, Dehmer GJ, Kennedy K et al. Appropriateness of percutaneous coronary intervention. JAMA 2011;306: 53-61.
13. National Institute for Cardiovascular Outcomes Research (NICOR), National Adult Cardiac Surgery Audit 2012.